GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 259 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2020. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $39,706,000 | +116.3% | 583,069 | +1.5% | 0.01% | +125.0% |
| Q2 2022 | $18,353,000 | -9.6% | 574,422 | -2.0% | 0.00% | 0.0% |
| Q1 2022 | $20,312,000 | +13.9% | 586,397 | -3.8% | 0.00% | +33.3% |
| Q4 2021 | $17,834,000 | +15.8% | 609,278 | +0.8% | 0.00% | 0.0% |
| Q3 2021 | $15,395,000 | -30.7% | 604,163 | -4.7% | 0.00% | -25.0% |
| Q2 2021 | $22,213,000 | +82.9% | 634,278 | +112.9% | 0.00% | +100.0% |
| Q1 2021 | $12,142,000 | -5.2% | 297,972 | +0.8% | 0.00% | 0.0% |
| Q4 2020 | $12,805,000 | -22.0% | 295,643 | -0.6% | 0.00% | -50.0% |
| Q3 2020 | $16,409,000 | -15.6% | 297,575 | -3.3% | 0.00% | -20.0% |
| Q2 2020 | $19,436,000 | -46.2% | 307,849 | -56.5% | 0.01% | -50.0% |
| Q1 2020 | $36,119,000 | -34.9% | 706,956 | +1.3% | 0.01% | -16.7% |
| Q4 2019 | $55,462,000 | +58.7% | 697,710 | -3.1% | 0.01% | +50.0% |
| Q3 2019 | $34,953,000 | +1.5% | 720,365 | +10.0% | 0.01% | 0.0% |
| Q2 2019 | $34,452,000 | +0.5% | 654,985 | +1.1% | 0.01% | 0.0% |
| Q1 2019 | $34,277,000 | +36.4% | 647,583 | +5.8% | 0.01% | +14.3% |
| Q4 2018 | $25,128,000 | +6.4% | 612,136 | -1.5% | 0.01% | +16.7% |
| Q3 2018 | $23,621,000 | -13.3% | 621,619 | +3.1% | 0.01% | -14.3% |
| Q2 2018 | $27,241,000 | +17.1% | 602,689 | +25.1% | 0.01% | +16.7% |
| Q1 2018 | $23,264,000 | +33.2% | 481,646 | +8.5% | 0.01% | +50.0% |
| Q4 2017 | $17,468,000 | +23.6% | 443,895 | -2.5% | 0.00% | 0.0% |
| Q3 2017 | $14,129,000 | +14.3% | 455,048 | +0.7% | 0.00% | +33.3% |
| Q2 2017 | $12,356,000 | +30.9% | 451,771 | +76.4% | 0.00% | 0.0% |
| Q1 2017 | $9,439,000 | +185.8% | 256,114 | +12.0% | 0.00% | +200.0% |
| Q4 2016 | $3,303,000 | -34.9% | 228,608 | +3.8% | 0.00% | -50.0% |
| Q3 2016 | $5,075,000 | +96.6% | 220,148 | +41.5% | 0.00% | +100.0% |
| Q2 2016 | $2,581,000 | +114.4% | 155,565 | +105.0% | 0.00% | – |
| Q1 2016 | $1,204,000 | -50.9% | 75,884 | +0.1% | 0.00% | -100.0% |
| Q4 2015 | $2,450,000 | +263.5% | 75,771 | +373.7% | 0.00% | – |
| Q3 2015 | $674,000 | – | 15,996 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |